FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809492509> ?p ?o ?g. }

• W2809492509 endingPage "370" @default.
• W2809492509 startingPage "363" @default.
• W2809492509 abstract "Currently, the national malaria control programme (NMCP) of Sierra Leone recommends artesunate–amodiaquine (ASAQ) and artemether–lumefantrine (AL) as first- and second-line treatment for uncomplicated malaria, respectively, and artesunate + sulfadoxine–pyrimethamine (SP) for intermittent preventive treatment during pregnancy and for infants. In 2016, the NMCP conducted a study to assess the clinical and parasitological responses of children under five years to ASAQ, AL and dihydroartemisinin–piperaquine (DHA/PPQ) according to the WHO protocol. Day-0 samples were tested for mutations in the Kelch 13 gene (pfk13) and dihydrofolate reductase/dihydropteroate synthase (pfdhfr/pfdhps) genes associated with artemisinin and SP resistance, respectively, and amplification in the pfplasmepsin2 gene for piperaquine resistance. A total of 295 (ASAQ = 128, AL = 64 and DHA/PPQ = 103) eligible children were enrolled at three sites. PCR-corrected 100% adequate clinical and parasitological response and no parasitaemia on day-3 were observed for all patients in each treatment group. Of the 278 samples with interpretable molecular data, only 2.2% carried non-synonymous pfk13 mutants (A578S, I646T), which are not associated with artemisinin resistance. None of the 103 day-0 samples from the DAH/PPQ group had pfplasmepsin2 gene amplification, confirming the absence of piperaquine resistance. The prevalence of the triple pfdhfr mutant (N51I/C59R/S108N) was close to or reached fixation (97.4–100%). For combined pfdhfr/pfdhps mutation, 55–71% carried the quadruple (N51I/C59R/S108N+A437G) mutant and about 10% the quintuple mutant N51I/C59R/S108N+A437G/K540E. Our findings confirm that ASAQ, AL and DHA/PPQ were highly effective for the treatment of uncomplicated malaria in the study areas, and neither pfk13 validated mutations nor pfplasmepsin2 multiple copies were found. The very low prevalence of the quintuple mutant in this study supports the NMCP’s decision to introduce intermittent preventive treatment for infants with SP in the districts with high malaria transmission." @default.
• W2809492509 created "2018-06-29" @default.
• W2809492509 creator A5014087860 @default.
• W2809492509 creator A5029615711 @default.
• W2809492509 creator A5032201964 @default.
• W2809492509 creator A5043524877 @default.
• W2809492509 creator A5058956390 @default.
• W2809492509 creator A5068098169 @default.
• W2809492509 creator A5090394978 @default.
• W2809492509 date "2018-09-01" @default.
• W2809492509 modified "2023-10-14" @default.
• W2809492509 title "Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone" @default.
• W2809492509 cites W1947887788 @default.
• W2809492509 cites W1978806509 @default.
• W2809492509 cites W1980413697 @default.
• W2809492509 cites W1989290058 @default.
• W2809492509 cites W1993347313 @default.
• W2809492509 cites W1996551849 @default.
• W2809492509 cites W2010272823 @default.
• W2809492509 cites W2042372663 @default.
• W2809492509 cites W2099198335 @default.
• W2809492509 cites W2102395543 @default.
• W2809492509 cites W2104700616 @default.
• W2809492509 cites W2107150651 @default.
• W2809492509 cites W2124634096 @default.
• W2809492509 cites W2130646906 @default.
• W2809492509 cites W2133048957 @default.
• W2809492509 cites W2137432389 @default.
• W2809492509 cites W2169329132 @default.
• W2809492509 cites W2171102256 @default.
• W2809492509 cites W2229864756 @default.
• W2809492509 cites W2344626565 @default.
• W2809492509 cites W2344718652 @default.
• W2809492509 cites W2467259677 @default.
• W2809492509 cites W2471559361 @default.
• W2809492509 cites W2547042202 @default.
• W2809492509 cites W2547295550 @default.
• W2809492509 cites W2584480708 @default.
• W2809492509 cites W2595820219 @default.
• W2809492509 cites W2608049415 @default.
• W2809492509 cites W2737472839 @default.
• W2809492509 cites W2741139908 @default.
• W2809492509 cites W2772765784 @default.
• W2809492509 doi "https://doi.org/10.1016/j.actatropica.2018.06.016" @default.
• W2809492509 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6058284" @default.
• W2809492509 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29932931" @default.
• W2809492509 hasPublicationYear "2018" @default.
• W2809492509 type Work @default.
• W2809492509 sameAs 2809492509 @default.
• W2809492509 citedByCount "12" @default.
• W2809492509 countsByYear W28094925092019 @default.
• W2809492509 countsByYear W28094925092020 @default.
• W2809492509 countsByYear W28094925092021 @default.
• W2809492509 countsByYear W28094925092022 @default.
• W2809492509 countsByYear W28094925092023 @default.
• W2809492509 crossrefType "journal-article" @default.
• W2809492509 hasAuthorship W2809492509A5014087860 @default.
• W2809492509 hasAuthorship W2809492509A5029615711 @default.
• W2809492509 hasAuthorship W2809492509A5032201964 @default.
• W2809492509 hasAuthorship W2809492509A5043524877 @default.
• W2809492509 hasAuthorship W2809492509A5058956390 @default.
• W2809492509 hasAuthorship W2809492509A5068098169 @default.
• W2809492509 hasAuthorship W2809492509A5090394978 @default.
• W2809492509 hasBestOaLocation W28094925091 @default.
• W2809492509 hasConcept C159047783 @default.
• W2809492509 hasConcept C162324750 @default.
• W2809492509 hasConcept C203014093 @default.
• W2809492509 hasConcept C2776120307 @default.
• W2809492509 hasConcept C2777035104 @default.
• W2809492509 hasConcept C2777234095 @default.
• W2809492509 hasConcept C2777616469 @default.
• W2809492509 hasConcept C2778048844 @default.
• W2809492509 hasConcept C2778059366 @default.
• W2809492509 hasConcept C2778371730 @default.
• W2809492509 hasConcept C2778629330 @default.
• W2809492509 hasConcept C2780441369 @default.
• W2809492509 hasConcept C2781160685 @default.
• W2809492509 hasConcept C3018567284 @default.
• W2809492509 hasConcept C47768531 @default.
• W2809492509 hasConcept C71924100 @default.
• W2809492509 hasConcept C86803240 @default.
• W2809492509 hasConceptScore W2809492509C159047783 @default.
• W2809492509 hasConceptScore W2809492509C162324750 @default.
• W2809492509 hasConceptScore W2809492509C203014093 @default.
• W2809492509 hasConceptScore W2809492509C2776120307 @default.
• W2809492509 hasConceptScore W2809492509C2777035104 @default.
• W2809492509 hasConceptScore W2809492509C2777234095 @default.
• W2809492509 hasConceptScore W2809492509C2777616469 @default.
• W2809492509 hasConceptScore W2809492509C2778048844 @default.
• W2809492509 hasConceptScore W2809492509C2778059366 @default.
• W2809492509 hasConceptScore W2809492509C2778371730 @default.
• W2809492509 hasConceptScore W2809492509C2778629330 @default.
• W2809492509 hasConceptScore W2809492509C2780441369 @default.
• W2809492509 hasConceptScore W2809492509C2781160685 @default.
• W2809492509 hasConceptScore W2809492509C3018567284 @default.
• W2809492509 hasConceptScore W2809492509C47768531 @default.
• W2809492509 hasConceptScore W2809492509C71924100 @default.
• W2809492509 hasConceptScore W2809492509C86803240 @default.

• next